[go: up one dir, main page]

RU96101801A - 2-Phenylindole derivatives, a mixture of their isomers or separate isomers and their salts, a pharmaceutical composition with anti-arteriosclerotic and anti-restenotic activity - Google Patents

2-Phenylindole derivatives, a mixture of their isomers or separate isomers and their salts, a pharmaceutical composition with anti-arteriosclerotic and anti-restenotic activity

Info

Publication number
RU96101801A
RU96101801A RU96101801/04A RU96101801A RU96101801A RU 96101801 A RU96101801 A RU 96101801A RU 96101801/04 A RU96101801/04 A RU 96101801/04A RU 96101801 A RU96101801 A RU 96101801A RU 96101801 A RU96101801 A RU 96101801A
Authority
RU
Russia
Prior art keywords
isomers
carbon atoms
mixture
branched alkyl
salts
Prior art date
Application number
RU96101801/04A
Other languages
Russian (ru)
Other versions
RU2162842C2 (en
Inventor
Мюллер-Глиманн Маттиас
Мюллер Ульрих
Бойк Мартин
Цайсс Зигфрид
ГЕРДЕС Кристоф
ДОМДАЙ-БЕТТЕ Анке
Грютцманн Руди
Ломер Штефан
Вольфайль Штефан
ЯЛКИНОГЛУ Ецкан
Денцер Дирк
ЭЛЬТИНГ Джеймс
Original Assignee
Байер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байер Аг filed Critical Байер Аг
Publication of RU96101801A publication Critical patent/RU96101801A/en
Application granted granted Critical
Publication of RU2162842C2 publication Critical patent/RU2162842C2/en

Links

Claims (4)

1. Производные 2-фенилиндола общей формулы I
Figure 00000001

где R1 - фенил, циклоалкил с 3 - 6 атомами углерода, неразветвленный или разветвленный алкил с 1 - 5 атомами углерода;
R2 - неразветвленный или разветвленный алкил с 1 - 8 атомами углерода или водород;
R3 - остаток формулы -СО-NН2 или -СН2-ОН;
смесь их изомеров или отдельные изомеры и их соли.
1. Derivatives of 2-phenylindole of the general formula I
Figure 00000001

where R 1 is phenyl, cycloalkyl with 3 to 6 carbon atoms, unbranched or branched alkyl with 1 to 5 carbon atoms;
R 2 is unbranched or branched alkyl with 1 to 8 carbon atoms or hydrogen;
R 3 is a residue of the formula —CO — NH 2 or —CH 2 —OH;
a mixture of their isomers or individual isomers and their salts.
2. Производные 2-фенилиндола общей формулы I по п.1,
где R1 - фенил, циклопропил, циклопентил, циклогексил, неразветвленный или разветственный алкил с 1 - 4 атомами углерода;
R2 - неразветственный или разветвленный алкил с 1 - 6 атомами углерода или водород;
R3 - остаток формулы -СО-NН2 или -СН2-ОН, смесь их изомеров или отдельные изомеры и их соли.
2. Derivatives of 2-phenylindole of the general formula I according to claim 1,
where R 1 is phenyl, cyclopropyl, cyclopentyl, cyclohexyl, unbranched or branched alkyl with 1 to 4 carbon atoms;
R 2 is a straight or branched alkyl with 1 to 6 carbon atoms or hydrogen;
R 3 is a residue of the formula —CO — NH 2 or —CH 2 —OH, a mixture of their isomers or individual isomers and their salts.
3. Производные 2-фенилиндола общей формулы I по п.1,
где R1 - фенил, циклопропил, этил, изо-пропил или н-бутил;
R2 - неразветвленный или разветвленный алкил с 1 - 5 атомами углерода или водород;
R3 - остаток формулы -СО-NН2 или -CH2-OH,
смесь их изомеров или отдельные изомеры и их соли.
3. Derivatives of 2-phenylindole of the general formula I according to claim 1,
where R 1 is phenyl, cyclopropyl, ethyl, iso-propyl or n-butyl;
R 2 is unbranched or branched alkyl with 1 to 5 carbon atoms or hydrogen;
R 3 is a residue of the formula —CO — NH 2 or —CH 2 —OH,
a mixture of their isomers or individual isomers and their salts.
4. Фармацевтическая композиция с антиартериосклеротической и антирестенозной активностью, содержащая по меньшей одну инертную нетоксичную, фармацевтически приемлемую целевую добавку и по меньшей мере одно активное начало, отличающаяся тем, что в качестве активного начала содержит соединение вышеуказанной общей формулы I
Figure 00000002

где R1 - фенил, циклоалкил с 3 - 6 атомами углерода, неразветвленный или разветвленный алкил с 1 - 5 атомами углерода;
R2 - неразветвленный или разветвленный алкил с 1 - 8 атомами углерода или водород;
R3 - остаток формулы -СО-NН2 или -СН2-ОН,
смесь его изомеров или отдельный изомер или его соль в эффективном количестве.
4. A pharmaceutical composition with anti-arteriosclerotic and anti-restenotic activity, comprising at least one inert non-toxic, pharmaceutically acceptable target additive and at least one active principle, characterized in that it contains a compound of the above general formula I as an active principle
Figure 00000002

where R 1 is phenyl, cycloalkyl with 3 to 6 carbon atoms, unbranched or branched alkyl with 1 to 5 carbon atoms;
R 2 is unbranched or branched alkyl with 1 to 8 carbon atoms or hydrogen;
R 3 is a residue of the formula —CO — NH 2 or —CH 2 —OH,
a mixture of its isomers or a single isomer or its salt in an effective amount.
RU96101801/04A 1995-02-01 1996-01-31 Derivatives of 2-phenylindole, mixture of their isomers or separate isomers or their physiologically acceptable salts, pharmaceutical composition showing antiproliferative activity RU2162842C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19503159 1995-02-01
DE19503159.8 1995-04-11

Publications (2)

Publication Number Publication Date
RU96101801A true RU96101801A (en) 1998-03-27
RU2162842C2 RU2162842C2 (en) 2001-02-10

Family

ID=7752848

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96101801/04A RU2162842C2 (en) 1995-02-01 1996-01-31 Derivatives of 2-phenylindole, mixture of their isomers or separate isomers or their physiologically acceptable salts, pharmaceutical composition showing antiproliferative activity

Country Status (10)

Country Link
KR (1) KR960031439A (en)
DE (2) DE19513716A1 (en)
MY (1) MY132270A (en)
RU (1) RU2162842C2 (en)
SG (1) SG38925A1 (en)
SV (1) SV1996000009A (en)
TN (1) TNSN96021A1 (en)
TW (1) TW349092B (en)
YU (1) YU5796A (en)
ZA (1) ZA96726B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517659A1 (en) * 1975-04-22 1976-11-11 Merck Patent Gmbh INDOLDER DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
WO1984002131A1 (en) * 1982-11-22 1984-06-07 Sandoz Ag Analogs of mevalolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3739882A1 (en) * 1987-11-25 1989-06-08 Bayer Ag SUBSTITUTED HYDROXYLAMINE
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides

Similar Documents

Publication Publication Date Title
KR920002608A (en) Rapamycin Derivatives
RU97112858A (en) SUBSTITUTED IMIDES AS INHIBITORS
ES8300112A1 (en) their starting compounds and their preparation.
RU99128073A (en) SUBSTITUTED 2- (2,6-DIOXOPIPERIDIN-3-IL) -PHTHALIMIDES AND -1-OXOISOINDOLINS AND METHOD FOR REDUCING THE FNOA LEVELS
RU95114449A (en) Derivatives of 4-aryl- or heteroaryl-6-amino-nicotinic acid, a mixture of their isomers or separate isomers, and also a pharmaceutical composition with a modulatory cali num ate ia i'm i'm i'm i'm i'm going
KR870700067A (en) Pyrido (2,3-d) -pyrimidine derivatives
RU96101800A (en) AMIDA DERIVATIVES OF PHENYLCYCLOGAXYLICARBONIC ACID, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERES AND THEIR SALT, PHARMACEUTICAL COMPOSITION WITH ANTI-ARTERIOCLEROTIC AND ANTI-RETENCY
RU98113525A (en) The use of 2-phenyl-3-aroylbenzothiophenes for the inhibition of thrombotic disorder, to increase the activation of protein C
IL69882A (en) Analgesia-effecting 5-hydroxytryptophan derivatives and pharmaceutical compositions comprising them
RU2000125889A (en) SUBSTITUTED BISINDOLYMALEIMIDES INTENDED TO INHIBIT CELL PROLIFERATION
DE3176274D1 (en) New cephem compounds and processes for preparation thereof
KR890016017A (en) Substituted 1- (1H-imidazol-4-yl) alkyl-benzamide
DK607783A (en) NITROALIPHATIC COMPOUNDS
KR950703941A (en) Nitrogen monoxide synthase inhibitor (NITROGEN MONOXIDE SYNTHESIS INHIBITOR)
RU96101801A (en) 2-Phenylindole derivatives, a mixture of their isomers or separate isomers and their salts, a pharmaceutical composition with anti-arteriosclerotic and anti-restenotic activity
KR900016178A (en) 2-substituted N, N'-ditrimethoxybenzoyl piperazine, preparation method thereof and therapeutic composition containing the same
GR3007599T3 (en)
DE3460841D1 (en) Mercaptoacetic acid and 3-mercaptopropionic acid amide derivatives for use in treatment of a human or animal body, some new derivatives and pharmaceutical compositions containing them
EA200100967A1 (en) NEW IMMUNE DEPRESSIVE MEANS
RU96115463A (en) DERIVATIVES OF 4H-PIRANA, A MIXTURE OF THEIR ISOMERS, SEPARATE ISOMERS AND THEIR SALTS, AND A PHARMACEUTICAL COMPOSITION FOR DIFFERENT MEDICAL TREATMENTS
RU96121791A (en) APPLICATION OF Xanthine derivatives to reduce the pathological hyperactivity of eosinophilic granulocytes, new xanthine derivatives and a method for their preparation
RU99113432A (en) NEW DERIVATIVES OF PHENANTRIDINIA
HUT43817A (en) Process for producing hydroxy-alkoxy-4-phenyl-propyl-indol derivatives and pharmaceutical compositions containing them as active agents
KR940014411A (en) New cephalosporin antibiotics (V)
ES8505653A1 (en) Treatment of migraine with N-alkyl-piperidinyl benzoate derivatives.